AmbioPharm Provides an Update on Shanghai Campus Expansion and Resumption of Customer Visits April 25, 2023 READ ARTICLE
Progress Update on AmbioPharm US-Based Microwave Peptide Synthesis Capabilities August 3, 2022 READ ARTICLE
Amytrx Therapeutics Partners With AmbioPharm to Expand the Potential of Its Breakthrough Leukocyte-Targeting Anti-Inflammatory Human Peptides July 26, 2022 READ ARTICLE
CEM Corporation and AmbioPharm Form U.S. Partnership for GMP Peptide Production September 14, 2021 READ ARTICLE
AmbioPharm Inc. Working with University of California Davis to Develop Non-Opioid Peptide-Based Pain Therapeutics July 20, 2021 READ ARTICLE